Mexico Clinical Trial Investigative Site Network Market Size & Outlook

The clinical trial investigative site network market in Mexico is expected to reach a projected revenue of US$ 107.6 million by 2030. A compound annual growth rate of 2.5% is expected of Mexico clinical trial investigative site network market from 2025 to 2030.
Revenue, 2024 (US$M)
$92.4
Forecast, 2030 (US$M)
$107.6
CAGR, 2025 - 2030
2.5%
Report Coverage
Mexico

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Mexico clinical trial investigative site network market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

Mexico clinical trial investigative site network market highlights

  • The Mexico clinical trial investigative site network market generated a revenue of USD 92.4 million in 2024 and is expected to reach USD 107.6 million by 2030.
  • The Mexico market is expected to grow at a CAGR of 2.5% from 2025 to 2030.
  • In terms of segment, phase iii was the largest revenue generating phase in 2024.
  • Phase I is the most lucrative phase segment registering the fastest growth during the forecast period.

Clinical trial investigative site network market data book summary

Market revenue in 2024USD 92.4 million
Market revenue in 2030USD 107.6 million
Growth rate2.5% (CAGR from 2025 to 2030)
Largest segmentPhase iii
Fastest growing segmentPhase I
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPhase I, Phase II, Phase III, Phase IV
Key market players worldwideIcon PLC, Velocity Clinical Research, IQVIA Holdings Inc, Elligo Health Research, WCG, ClinChoice昆翎, Access Clinical Partners, Fomat Medical Research, SGS AG, KV Clinical Research Services, SMO-Group, Xylem Inc, Aurum Healthcare

Other key industry trends

  • In terms of revenue, Mexico accounted for 1.1% of the global clinical trial investigative site network market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. clinical trial investigative site network market is projected to lead the regional market in terms of revenue in 2030.
  • U.S. is the fastest growing regional market in North America and is projected to reach USD 4,623.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Clinical Trial Investigative Site Network Market Companies

Name Profile # Employees HQ Website
Velocity Clinical Research View profile 1001-5000 Durham, North Carolina, United States, North America https://www.velocityclinical.com/
SMO-Group View profile 101-250 Kiev, Kyyivs'ka Oblast', Ukraine, Europe https://www.smo-group.com/
Aurum Healthcare View profile - Gelang Patah, Johor, Malaysia, Asia http://www.aurumhealthcare.com/
KV Clinical Research Services View profile 11-50 Raipur, Chhattisgarh, India, Asia https://www.kvclinicalresearch.com
Fomat Medical Research View profile 51-100 Oxnard, California, United States, North America http://fomatmedical.com/
Access Clinical Partners View profile - Gresham, Oregon, United States, North America -
ClinChoice昆翎 View profile 1001-5000 Shanghai, Shanghai, China, Asia https://www.clinchoice.com.cn
Elligo Health Research View profile 251-500 Austin, Texas, United States, North America https://www.elligohealthresearch.com/
WCG View profile 1001-5000 Princeton, New Jersey, United States, North America http://www.wcgclinical.com/
SGS AG View profile 103193 1 Place des Alpes, P.O. Box 2152, Geneva, Switzerland, CH-1211 https://www.sgs.com
IQVIA Holdings Inc View profile 87000 2400 Ellis Road, Durham, NC, United States, 27703 https://www.iqvia.com
Icon PLC View profile 41150 South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 https://www.iconplc.com
Xylem Inc View profile 23000 300 Water Street SE, Washington, DC, United States, 20003 https://www.xylem.com

Mexico clinical trial investigative site network market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial investigative site network market will help companies and investors design strategic landscapes.


Phase iii was the largest segment with a revenue share of 56.06% in 2024. Horizon Databook has segmented the Mexico clinical trial investigative site network market based on phase i, phase ii, phase iii, phase iv covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Mexico clinical trial investigative site network market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Mexico clinical trial investigative site network market databook

  • Our clientele includes a mix of clinical trial investigative site network market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Mexico clinical trial investigative site network market , including forecasts for subscribers. This country databook contains high-level insights into Mexico clinical trial investigative site network market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Mexico clinical trial investigative site network market size, by phase, 2018-2030 (US$M)

Mexico Clinical Trial Investigative Site Network Market Outlook Share, 2024 & 2030 (US$M)

Mexico clinical trial investigative site network market size, by phase, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online